Lataa...
Comparing and Combining Biomarkers as Principle Surrogates for Time-to-Event Clinical Endpoints
Principal surrogate endpoints are useful as targets for Phase I and II trials. In many recent trials, multiple post-randomization biomarkers are measured. However, few statistical methods exist for comparison of or combination of biomarkers as principal surrogates and none of these methods to our kn...
Tallennettuna:
| Julkaisussa: | Stat Med |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4801510/ https://ncbi.nlm.nih.gov/pubmed/25352131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.6349 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|